KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cerence (CRNC) Gains from Investment Securities (2018 - 2025)

Cerence's Gains from Investment Securities history spans 8 years, with the latest figure at $426000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 77.19% year-over-year to $426000.0; the TTM value through Dec 2025 reached -$5.2 million, down 376.6%, while the annual FY2025 figure was $6.7 million, 99.71% down from the prior year.
  • Gains from Investment Securities reached $426000.0 in Q4 2025 per CRNC's latest filing, down from $2.0 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $5.9 million in Q3 2021 to a low of -$9.6 million in Q3 2022.
  • Average Gains from Investment Securities over 5 years is $577074.4, with a median of $971505.5 recorded in 2021.
  • Peak YoY movement for Gains from Investment Securities: skyrocketed 16152.78% in 2021, then tumbled 865.8% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $155000.0 in 2021, then skyrocketed by 1486.45% to $2.5 million in 2022, then decreased by 18.85% to $2.0 million in 2023, then dropped by 6.42% to $1.9 million in 2024, then plummeted by 77.19% to $426000.0 in 2025.
  • Per Business Quant, the three most recent readings for CRNC's Gains from Investment Securities are $426000.0 (Q4 2025), $2.0 million (Q3 2025), and $100000.0 (Q2 2025).